CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
12.04
2.82%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.09
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 11.71
Open 11.83
1-Year Change 13.86%
Day's Range 11.83 - 12.11
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 25, 2024 11.72 0.05 0.43% 11.67 11.90 11.67
Jul 24, 2024 11.65 0.08 0.69% 11.57 11.74 11.48
Jul 23, 2024 11.45 -0.14 -1.21% 11.59 11.60 11.39
Jul 22, 2024 11.62 -0.08 -0.68% 11.70 11.76 11.52
Jul 19, 2024 11.80 0.04 0.34% 11.76 11.82 11.61
Jul 18, 2024 11.74 -0.02 -0.17% 11.76 12.11 11.70
Jul 17, 2024 11.79 0.46 4.06% 11.33 11.86 11.29
Jul 16, 2024 11.34 0.41 3.75% 10.93 11.38 10.89
Jul 15, 2024 10.96 -0.23 -2.06% 11.19 11.20 10.92
Jul 12, 2024 11.20 0.03 0.27% 11.17 11.38 11.16
Jul 11, 2024 11.15 0.21 1.92% 10.94 11.16 10.81
Jul 10, 2024 10.85 0.10 0.93% 10.75 10.93 10.69
Jul 9, 2024 10.77 0.25 2.38% 10.52 10.93 10.43
Jul 8, 2024 10.59 0.28 2.72% 10.31 10.59 10.30
Jul 5, 2024 10.30 0.05 0.49% 10.25 10.31 10.10
Jul 3, 2024 10.33 -0.07 -0.67% 10.40 10.46 10.30
Jul 2, 2024 10.40 -0.22 -2.07% 10.62 10.62 10.29
Jul 1, 2024 10.55 -0.01 -0.09% 10.56 10.74 10.50
Jun 28, 2024 10.59 0.11 1.05% 10.48 10.68 10.46
Jun 27, 2024 10.44 0.09 0.87% 10.35 10.54 10.28

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Viatris Inc. Company profile

Viatris (VTRS) is a global healthcare company. It was formed in 2020 through the merger of Pfizer’s (PFE) off-patent branded and generic medicines division Upjohn and pharmaceutical firm Mylan. 

The merger of Mylan and Upjohn was announced in July 2019 and received final regulatory clearance in October 2020. Pfizer shareholders own 57% of Viatris and Mylan shareholders own 43%, according to the merger announcement. Viatris started trading on the Nasdaq Stock Exchange under the ticker VTRS in November 2020. 

Viatris is headquartered in Canonsburg, Pittsburgh, US. The company is operational in over 165 countries and has global centres in Shanghai, China and Hyderabad, India. 

Viatris operates about 40 manufacturing sites which produce oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients. The firm also produces numerous complex generics, biosimilars and global key brands.

Viatris offers treatment options across more than 10 major therapeutic areas covering a wide variety of non-communicable and infectious diseases. According to the company’s website, 50% of its total active pharmaceutical ingredient (API) capacity is devoted to antiretroviral (ARV), which is used against HIV infection. 

Some of the well-known and key brands under Viatris are anxiety treatment drug Xanax, antidepressant Zoloft, anti-inflammatory drug Celebrex and erectile dysfunction therapy Viagra, among others. Viatris also offers global biosimilars franchises focused on the areas of oncology, immunology, endocrinology, ophthalmology and dermatology.

Industry: Pharmaceuticals (NEC)

1000 Mylan Boulevard
CANONSBURG
PENNSYLVANIA 15317
US

People also watch

BTC/USD

68,006.70 Price
+4.100% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Gold

2,387.21 Price
+0.940% 1D Chg, %
Long position overnight fee -0.0190%
Short position overnight fee 0.0108%
Overnight fee time 21:00 (UTC)
Spread 0.60

ETH/USD

3,280.77 Price
+3.990% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

US100

19,029.00 Price
+1.080% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading